Letter to industry – Changes to treatment of crypto-assets exposures

Information
Publication type
Letter
Category
Capital Adequacy Requirements
Date
Sector
Banks,
Cooperative Credit Associations,
Foreign Bank Branches,
Life Insurance and Fraternal Companies,
Property and Casualty Companies,
Trust and Loan Companies
Table of contents

In response to developments in the crypto markets and following valuable feedback from stakeholders, the Office of the Superintendent to Financial Institutions (OSFI) has made some targeted changes to the Capital and Liquidity Treatment of Crypto-asset Exposures (Banking) – Guideline and the Capital Treatment of Crypto-asset Exposures (Insurance) – Guideline.

Under the revised guidelines:

  • an institution’s total gross exposure to Group 2 crypto-assets should not exceed 5% of the institution’s Net Tier 1 capital.
  • we have removed the requirement that Group 2 crypto-asset exposures above 1% of an institution’s Net Tier 1 capital be subject to the capital requirements that apply to Group 2b crypto-asset exposures.  

These changes come into effect November 1, 2025, or January 1, 2026, for institutions with a fiscal year ending October 31, or December 31, respectively.

The guidelines reflect considerable consultation with stakeholders and offer a more risk-sensitive approach than the Interim arrangements for the regulatory capital and liquidity treatment of cryptoasset exposures that have been in place since August 2022.

Given the dynamic nature of the crypto market and to support continued innovation, we are continuing to examine several key issues. These include:

  • the risk weight applied to Group 2a assets
  • the potential recognition of Group 2a assets as collateral
  • the treatment of cross-market hedges

We will address these areas through continued engagement and consultation with industry participants to ensure that the guidelines remain well-aligned with the underlying risks to the Canadian financial system.

In addition, we have published responses to frequently asked questions (FAQs) about the application of the guidelines.